Literature DB >> 16314881

Comparative genomics analysis of human sequence variation in the UGT1A gene cluster.

M L Maitland1, C Grimsley, H Kuttab-Boulos, D Witonsky, K E Kasza, L Yang, B A Roe, A Di Rienzo.   

Abstract

Common polymorphisms within the human UGT1A gene locus are associated with irinotecan and tranilast toxicity. To uncover additional functional variation across this gene cluster, cross-species sequence comparisons were performed. Evolutionarily conserved segments (a total of 47.1 kb) were re-sequenced in 24 African-American, 24 European-American, and 24 Asian individuals, and 381 segregating sites (including 123 singletons) were identified. Highly conserved coding sites were less likely to be polymorphic than diverged sites (P<0.0001) but this pattern was not observed at non-coding sites (P=0.1025). Among coding variants, the distribution of those computationally predicted to affect function was skewed toward low frequencies. Some alleles occurred at similar frequencies in each population; others had wide disparities. Although strong linkage disequilibrium was detected among the hepatically expressed genes, the degree of linkage disequilibrium varied among populations. These results suggest that rare functional gene variants and inter-population variability must be considered in the interpretation of association studies between UGT1A and drug metabolism/toxicity phenotypes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16314881     DOI: 10.1038/sj.tpj.6500351

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  13 in total

Review 1.  The pharmacogenetics research network: from SNP discovery to clinical drug response.

Authors:  K M Giacomini; C M Brett; R B Altman; N L Benowitz; M E Dolan; D A Flockhart; J A Johnson; D F Hayes; T Klein; R M Krauss; D L Kroetz; H L McLeod; A T Nguyen; M J Ratain; M V Relling; V Reus; D M Roden; C A Schaefer; A R Shuldiner; T Skaar; K Tantisira; R F Tyndale; L Wang; R M Weinshilboum; S T Weiss; I Zineh
Journal:  Clin Pharmacol Ther       Date:  2007-03       Impact factor: 6.875

2.  UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens.

Authors:  Chengxu Cui; Chang Shu; Dandan Cao; Yi Yang; Junbao Liu; Shuping Shi; Zhujun Shao; Nan Wang; Ting Yang; Hao Liang; Shanshan Zou; Songnian Hu
Journal:  Oncol Lett       Date:  2016-09-14       Impact factor: 2.967

3.  SNP discovery, expression and cis-regulatory variation in the UGT2B genes.

Authors:  C Sun; C Southard; D Huo; R D Hernandez; D B Witonsky; O I Olopade; A Di Rienzo
Journal:  Pharmacogenomics J       Date:  2011-03-01       Impact factor: 3.550

4.  Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens.

Authors:  Eric Lévesque; Anne-Sophie Bélanger; Mario Harvey; Félix Couture; Derek Jonker; Federico Innocenti; Erica Cecchin; Giuseppe Toffoli; Chantal Guillemette
Journal:  J Pharmacol Exp Ther       Date:  2013-02-05       Impact factor: 4.030

5.  Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels--the Framingham Heart Study.

Authors:  Jing-Ping Lin; Johannes P Schwaiger; L Adrienne Cupples; Christopher J O'Donnell; Gang Zheng; Veit Schoenborn; Steven C Hunt; Jungnam Joo; Florian Kronenberg
Journal:  Atherosclerosis       Date:  2009-03-19       Impact factor: 5.162

6.  Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver.

Authors:  Wanqing Liu; Jacqueline Ramírez; Eric R Gamazon; Snezana Mirkov; Peixian Chen; Kehua Wu; Chang Sun; Nancy J Cox; Edwin Cook; Soma Das; Mark J Ratain
Journal:  Hum Mol Genet       Date:  2014-05-30       Impact factor: 6.150

7.  Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans.

Authors:  Dezheng Huo; Hee-Jin Kim; Clement A Adebamowo; Temidayo O Ogundiran; Effiong E Akang; Oladapo Campbell; Adeniyi Adenipekun; Qun Niu; Lise Sveen; James D Fackenthal; Donna Lee Fackenthal; Soma Das; Nancy Cox; Anna Di Rienzo; Olufunmilayo I Olopade
Journal:  Breast Cancer Res Treat       Date:  2007-10-02       Impact factor: 4.872

8.  The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions.

Authors:  Andrea Y Angstadt; Terryl J Hartman; Samuel M Lesko; Joshua E Muscat; Junjia Zhu; Carla J Gallagher; Philip Lazarus
Journal:  Genes Chromosomes Cancer       Date:  2014-06       Impact factor: 5.006

9.  Genetic variations and haplotype diversity of the UGT1 gene cluster in the Chinese population.

Authors:  Jing Yang; Lei Cai; Haiyan Huang; Bingya Liu; Qiang Wu
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

10.  Polymorphic expression of UDP-glucuronosyltransferase UGTlA gene in human colorectal cancer.

Authors:  Min Wang; De-Feng Sun; Shuai Wang; Ying Qing; Shuo Chen; Dong Wu; Ying-Min Lin; Ji-Zhuang Luo; Yan-Qing Li
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.